The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Van Parijs, L., Refaeli, Y., Lord, J. D., Nelson, B. H., Abbas, A. K., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80103-x · Cited by 423
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Akira, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300028200 · Cited by 1,479
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Regulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Cytokine control of memory T-cell development and survival
Schluns, K. S., & Lefrançois, L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1052 · Cited by 882
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
Andreola, G., Rivoltini, L., Castelli, C., Huber, V., Perego, P., Deho, P., Squarcina, P., Accornero, P., Lozupone, F., Lugini, L., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011624 · Cited by 774
Tolerance, DCs and tryptophan: much ado about IDO
Grohmann, U. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00072-3 · Cited by 766
TGF- β signaling in cancer – a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02130-4 · Cited by 756
Matzinger, P. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0143 · Cited by 748
Environment and Cancer: Who Are Susceptible?
Perera, F. P. (1997) · Science · doi:10.1126/science.278.5340.1068 · Cited by 638
Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice
Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., & Ochoa, A. C. (1992) · Science · doi:10.1126/science.1465616 · Cited by 632
Human Cancer Syndromes: Clues to the Origin and Nature of Cancer
Fearon, E. R. (1997) · Science · doi:10.1126/science.278.5340.1043 · Cited by 605
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
Kim, J. W., Wieckowski, E., Taylor, D. D., Reichert, T. E., Watkins, S., & Whiteside, T. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1010.11.3 · Cited by 497
Self-citationInsights into the mechanisms of lymph node metastasis
Nathanson, S. D. (2003) · Cancer · doi:10.1002/cncr.11464 · Cited by 433
Decreased antigen presentation by dendritic cells in patients with breast cancer.
Gabrilovich, D. I., Corak, J., Ciernik, I. F., Kavanaugh, D., & Carbone, D. P. (1997) · PubMed · Cited by 429
(1996) · Nature Medicine · doi:10.1038/nm1196-1267 · Cited by 429
Hoffmann, T. K., Dworacki, G., Tsukihiro, T., Meidenbauer, N., Gooding, W. E., Johnson, J. T., & Whiteside, T. L. (2002) · PubMed · Cited by 388
Self-citationLoss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.
Finke, J. H., Zea, A. H., Stanley, J., Longo, D., Mizoguchi, H., Tubbs, R. R., Wiltrout, R. H., O’Shea, J. J., Kudoh, S., & Klein, E. A. (1993) · PubMed · Cited by 379
Marrack, P., & Kappler, J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104554 · Cited by 362
The Roles of Costimulation and Fas in T Cell Apoptosis and Peripheral Tolerance
Van Parijs, L., Ibraghimov, A., & Abbas, A. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80440-9 · Cited by 351
Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J., Vivier, É., Anderson, P., & Kiessling, R. W. (1993) · PubMed · Cited by 339
Suganuma, M., Okabe, S., Marino, M. W., Sakai, A., Sueoka, E., & Fujiki, H. (1999) · PubMed · Cited by 303
The role of natural killer cells in immune surveillance of cancer
Whiteside, T. L., & Herberman, R. B. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80080-8 · Cited by 280
Self-citationSchaefer, C., Kim, G. G., Albers, A., Hoermann, K., Myers, E. N., & Whiteside, T. L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602407 · Cited by 271
Self-citationMeissner, M., Reichert, T. E., Kunkel, M., Gooding, W., Whiteside, T. L., Ferrone, S., & Seliger, B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2146 · Cited by 266
Self-citationKuss, I., Hathaway, B., Ferris, R. L., Gooding, W., & Whiteside, T. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0054 · Cited by 263
Self-citationMocellin, S., Marincola, F., Riccardo Rossi, C., Nitti, D., & Lise, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.11.001 · Cited by 247
Taylor, D. D., Gerçel-Taylor, Ç., Lyons, K. S., Stanson, J., & Whiteside, T. L. (2003) · PubMed · Cited by 247
Self-citationExpression pattern of S100 calcium-binding proteins in human tumors
Ilg, E. C., Schäfer, B. W., & Heizmann, C. W. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961104)68:3<276::aid-ijc2>3.0.co;2-z · Cited by 231
Lai, P., Rabinowich, H., Crowley‐Nowick, P. A., Bell, M. C., Mantovani, G., & Whiteside, T. L. (1996) · PubMed · Cited by 218
Self-citationReichert, T. E., Strauss, L., Wagner, E. M., Gooding, W. E., & Whiteside, T. L. (2002) · PubMed · Cited by 211
Self-citationRegulatory T cells in autoimmunity
Leavy, O. (2007) · Nature Reviews Immunology · doi:10.1038/nri2078 · Cited by 205
Immune responses to malignancies
Whiteside, T. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.045 · Cited by 204
Self-citationMantovani, A. (1994) · PubMed · Cited by 204
Alterations in T cell receptor and signal transduction molecules in melanoma patients.
Zea, A. H., Curti, B. D., Longo, D. L., Alvord, W. G., Strobl, S., Mizoguchi, H., Creekmore, S. P., O’Shea, J. J., Powers, G. C., & Urba, W. J. (1995) · PubMed · Cited by 190
Seliger, B., Ritz, U., Abele, R., Bock, M., Tampé, R., Sutter, G., Drexler, I., Huber, C., & Ferrone, S. (2001) · PubMed · Cited by 189
Kono, K., Ressing, M. E., Brandt, R. M. P., Melief, C. J. M., Potkul, R. K., Andersson, B., Petersson, M., Kast, W. M., & Kiessling, R. W. (1996) · PubMed · Cited by 164
Tumor Gangliosides Inhibit the Tumor-Specific Immune Response
McKallip, R., Li, R., & Ladisch, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3718 · Cited by 164
Tumor-induced death of immune cells: its mechanisms and consequences
Whiteside, T. L. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0402 · Cited by 151
Self-citationDown-regulation of ?-chain expression in T cells: a biomarker of prognosis in cancer?
Whiteside, T. L. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0521-0 · Cited by 151
Self-citationReichert, T. E., Day, R., Wagner, E. M., & Whiteside, T. L. (1998) · PubMed · Cited by 147
Self-citationSogn, J. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80641-x · Cited by 140
HLA class I antigen loss, tumor immune escape and immune selection
Campoli, M. R., Chang, C., & Ferrone, S. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00386-9 · Cited by 131
Mechanisms Responsible for Signaling and Functional Defects
Reichert, T. E., Rabinowich, H., Johnson, J. T., & Whiteside, T. L. (1998) · Journal of Immunotherapy · doi:10.1097/00002371-199807000-00007 · Cited by 127
Self-citationRenal cell carcinoma–derived gangliosides suppress nuclear factor-κB activation in T cells
Uzzo, R. G., Rayman, P. A., Kolenko, V. M., Clark, P. E., Cathcart, M. K., Bloom, T., Novick, A. C., Bukowski, R. M., Hamilton, T. A., & Finke, J. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6775 · Cited by 124
Animal models of tumor immunity, immunotherapy and cancer vaccines
Ostrand‐Rosenberg, S. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.003 · Cited by 123
Fatal attraction: tumors beckon regulatory T cells
Shevach, E. M. (2004) · Nature Medicine · doi:10.1038/nm0904-900 · Cited by 121
The Role of Immune Cells in the Tumor Microenvironment
Whiteside, T. L. (2006) · Cancer treatment and research · doi:10.1007/0-387-26283-0_5 · Cited by 119
Self-citationWang, S., & Chen, L. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.03.007 · Cited by 119
Ferris, R. L., Hunt, J. L., & Ferrone, S. (2005) · Immunologic Research · doi:10.1385/ir:33:2:113 · Cited by 117
Interleukin‐10 in viral diseases and cancer: exiting the labyrinth?
Vicari, A. P., & Trinchieri, G. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00216.x · Cited by 112
Rabinowich, H., Banks, M., Reichert, T. E., Logan, T. F., Kirkwood, J. M., & Whiteside, T. L. (1996) · PubMed · Cited by 110
Self-citationAlbers, A. E., Ferris, R. L., Kim, G. G., Chikamatsu, K., DeLeo, A. B., & Whiteside, T. L. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0670-9 · Cited by 105
Self-citationHoffmann, T. K., Donnenberg, A. D., Finkelstein, S. D., Donnenberg, V. S., Friebe-Hoffmann, U., Myers, E. N., Appella, E., DeLeo, A. B., & Whiteside, T. L. (2002) · PubMed · Cited by 103
Self-citationDendritic cell biology and cancer therapy
Whiteside, T. L., & Odoux, C. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0468-6 · Cited by 97
Self-citationHoffmann, T. K., Nakano, K., Elder, E. M., Dworacki, G., Finkelstein, S. D., Appella, E., Whiteside, T. L., & DeLeo, A. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5938 · Cited by 91
Self-citationEvidence for an antigen-driven humoral immune response in medullary ductal breast cancer.
Coronella, J. A., Telleman, P., Kingsbury, G. A., Truong, T., Hays, S. R., & Junghans, R. P. (2001) · PubMed · Cited by 88
Alterations in NF B Activation in T Lymphocytes of Patients With Renal Cell Carcinoma
Uzzo, R. G., Clark, P., Rayman, P. A., Bloom, T., Rybicki, L. A., Novick, A. C., Bukowski, R. M., & Finke, J. H. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.8.718 · Cited by 88
Monoclonal antibodies in human cancer.
Mellstedt, H. (2003) · PubMed · Cited by 84
Regulation of tumour immunity by CD25+ T cells
Gallimore, A., & Sakaguchi, S. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01471.x · Cited by 80
Is human immunosenescence clinically relevant? Looking for ‘immunological risk phenotypes’
Pawelec, G., Ouyang, Q., Colonna‐Romano, G., Candore, G., Lio, D., & Caruso, C. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02255-x · Cited by 78
Chemokine C Receptor 7 Expression and Protection of Circulating CD8+ T Lymphocytes from Apoptosis
Kim, J., Ferris, R. L., & Whiteside, T. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1346 · Cited by 76
Self-citationBukowski, R. M., Rayman, P. A., Uzzo, R. G., Bloom, T., Sandstrom, K., Peereboom, D. M., Olencki, T. E., Budd, G. T., McLain, D., Elson, P. J., et al. (1998) · PubMed · Cited by 75
Whiteside, T. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00387-0 · Cited by 73
Self-citationThe role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer
Uotila, P. J. (1996) · Cancer Immunology Immunotherapy · doi:10.1007/bf03354243 · Cited by 71
Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity
Strayer, D. R., Carter, W. A., & Brodsky, I. (1986) · Breast Cancer Research and Treatment · doi:10.1007/bf01806249 · Cited by 66
Taylor, D. D., Bender, D., Gerçel‐Taylor, Ç., Stanson, J., & Whiteside, T. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1847 · Cited by 55
Self-citationKurt, R. A., Urba, W. J., Smith, J. W., & Schoof, D. D. (1998) · International Journal of Cancer · Cited by 51
Direct visualization of antigen-specific T cells using peptide-MHC-class I tetrameric complexes
Meidenbauer, N., Hoffmann, T. K., & Donnenberg, A. D. (2003) · Methods · doi:10.1016/s1046-2023(03)00126-9 · Cited by 46
Kim, J., Tsukishiro, T., Johnson, J. T., & Whiteside, T. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0309 · Cited by 44
Self-citationTumor-infiltrating lymphocytes as antitumor effector cells
Whiteside, T. L. (1992) · Biotherapy · doi:10.1007/bf02194785 · Cited by 43
Self-citationLymphocyte-mediated immunosurveillance of epithelial cancers?
Smyth, M. J., & Trapani, J. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01977-9 · Cited by 42
Lybarger, L. P., Wang, X., Harris, M., & Hansen, T. H. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.11.009 · Cited by 40
Familial cancer, emotional distress, and low natural cytotoxic activity in healthy women
Bovbjerg, D. H., & Valdimarsdottir, H. B. (1993) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058659 · Cited by 37
López, C. B., Rao, T. D., Feiner, H. D., Shapiro, R. L., Marks, J. R., & Frey, A. B. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1390 · Cited by 33
Kuss, I., Schaefer, C., Godfrey, T. E., Ferris, R. L., Harris, J. M., Gooding, W. E., & Whiteside, T. L. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.12.011 · Cited by 32
Self-citationThe use of HLA class I tetramers to design a vaccination strategy for melanoma patients
Palmowski, M. J., Salio, M., Dunbar, P. R., & Cerundolo, V. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18814.x · Cited by 25
Young, M. R. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0456-x · Cited by 21
Reuben, J., & Hersh, E. M. (1984) · PubMed · Cited by 20
Mechanisms of Tumor Escape from the Immune Response
Ochoa, A. (2002) · doi:10.1201/9780367804701 · Cited by 15
Immune Escape: Tumor induced immune suppression and immune escape: Mechanisms and Possible Solutions
Whiteside, T. L., Campoli, M. R., & Ferrone, S. (2005) · Springer eBooks · doi:10.1007/1-4020-3623-x_3 · Cited by 9
Self-citation
Cited by
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Self-citationImmunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
Gao, J., Xu, K., Liu, H., Liu, G., Bai, M., Peng, C., Li, T., & Yin, Y. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00013 · Cited by 1,298
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 831
Deciphering and Reversing Tumor Immune Suppression
Motz, G. T., & Coukos, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.005 · Cited by 598
Metadata
- Authors
- WHITESIDE, T.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 16
- Issue
- 1
- Pages
- 3-15
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W1979842508
- Cited by
- 487
- References
- 96
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.